Your browser doesn't support javascript.
loading
Gender difference analysis of Xp11.2 translocation renal cell carcinomas's attack rate: a meta-analysis and systematic review.
Zhuang, Wenyuan; Liu, Ning; Guo, Hongqian; Zhang, Chunni; Gan, Weidong.
Afiliación
  • Zhuang W; Department of Urology, Nanjing Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University, 321 Zhongshan Road, Nanjing, 210008, China.
  • Liu N; Department of Urology, Nanjing Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University, 321 Zhongshan Road, Nanjing, 210008, China.
  • Guo H; Department of Urology, Nanjing Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University, 321 Zhongshan Road, Nanjing, 210008, China.
  • Zhang C; Department of Clinical Laboratory, Jinling Hospital, State Key Laboratory of Analytical Chemistry for Life Science, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, Nanjing University School of Medicine, Nanjing University, Nanjing, China. zchunni27@hotmail.com.
  • Gan W; Department of Urology, Nanjing Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University, 321 Zhongshan Road, Nanjing, 210008, China. gwd@nju.edu.cn.
BMC Urol ; 20(1): 130, 2020 Aug 26.
Article en En | MEDLINE | ID: mdl-32843027
ABSTRACT

BACKGROUND:

Xp11.2 translocation renal cell carcinoma (tRCC) is recently recognized. As Xp11.2 tRCC involved gene translocation and fusion in X chromosome and the number of X chromosomes in female is twice of male, we wondered whether the gender difference of attack rate is consistent with the proportion of the X chromosome.

METHODS:

In the present paper, meta-analysis was performed to find out the difference of morbidity between male and female.

RESULTS:

Nine studies with 209 cases calculated. Odds ratios (ORs) and ORs with 95% confidence intervals (CIs) were calculated for attack rate of Xp11.2 RCC with different gender. The result showed that the attack rate of female was higher than that of male with pooled OR of 2.84 (95% CI = 1.48-5.45), while the rate rises even further in adult (OR = 3.37, 95% CI =2.19-5.18). In other types of common kidney cancer, the OR value is less than 1, which means that the incidence of female is lower than that of male.

CONCLUSIONS:

The result showed that the incidence rate of female patients is much higher than that of male patients with Xp11.2 tRCC, it was reasonable to indicate that this particular incidence rate is related to the X chromosome.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Translocación Genética / Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Systematic_reviews Límite: Female / Humans / Male Idioma: En Revista: BMC Urol Asunto de la revista: UROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Translocación Genética / Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Systematic_reviews Límite: Female / Humans / Male Idioma: En Revista: BMC Urol Asunto de la revista: UROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: China